IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101 | -19.8% | 22,306 | +24.8% | 0.00% | 0.0% |
| Q2 2023 | $126 | +32.6% | 17,872 | +14.9% | 0.00% | 0.0% |
| Q1 2023 | $95 | -22.8% | 15,551 | -19.1% | 0.00% | 0.0% |
| Q4 2022 | $123 | -99.9% | 19,233 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $184,000 | -12.4% | 19,233 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $210,000 | -56.2% | 19,046 | -34.0% | 0.00% | -50.0% |
| Q1 2022 | $480,000 | -55.5% | 28,847 | -48.9% | 0.00% | 0.0% |
| Q4 2021 | $1,078,000 | +63.8% | 56,428 | +111.3% | 0.00% | -33.3% |
| Q3 2021 | $658,000 | -9.0% | 26,700 | -3.9% | 0.01% | 0.0% |
| Q2 2021 | $723,000 | -11.0% | 27,790 | +8.4% | 0.01% | -80.0% |
| Q1 2021 | $812,000 | -37.2% | 25,632 | -8.0% | 0.03% | -38.8% |
| Q4 2020 | $1,293,000 | +40.8% | 27,866 | -0.0% | 0.05% | +22.5% |
| Q3 2020 | $918,000 | +19.2% | 27,872 | -0.6% | 0.04% | +11.1% |
| Q2 2020 | $770,000 | +21.8% | 28,050 | +32.9% | 0.04% | +140.0% |
| Q1 2020 | $632,000 | +3.6% | 21,100 | -4.2% | 0.02% | +36.4% |
| Q4 2019 | $610,000 | +65.3% | 22,034 | +8.6% | 0.01% | +37.5% |
| Q3 2019 | $369,000 | -26.8% | 20,297 | -1.3% | 0.01% | -33.3% |
| Q2 2019 | $504,000 | +247.6% | 20,559 | +34.7% | 0.01% | +200.0% |
| Q1 2019 | $145,000 | +11.5% | 15,265 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $130,000 | -19.3% | 14,634 | +16.3% | 0.00% | 0.0% |
| Q2 2018 | $161,000 | – | 12,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |